Research has shown that the maker of Avandia, GlaxoSmithKline, may have known of the dangers of the drug even as they continued to market it on a widespread scale to patients. Major studies have shown that taking Avandia can increase your risk for a heart attack by as much as 43% and your risk of cardiovascular-related death by as much as 60%. This affects millions of Americans who have taken the drug for diabetes. Lawyers are currently filing Avandia heart attack lawsuits for those who have taken the drug and been affected by any cardiovascular condition. Settlements are available within months based on prior awards. Tens of thousands of people have received legal help after suffering an Avandia-related injury. However, there are still people who are taking the drug and many more who have not been compensated for their damages. Legal help is still available.

What is Avandia

Avandia or rosiglitazone maleate is a commonly prescribed medication for people with Type 2 diabetes. Its use was approved in 1999. It acts as an adjunct to exercise and diet in controlling one’s blood sugar levels. The estimated number of people using Avandia these days is more than 6 million Type 2 diabetic patients.

Avandia Warning

The FDA issued it’s first Avandia warning about increased heart attacks risks on May 21, 2007. Unfortunately, for the tens of thousands of people the drug harmed, the FDA determined the data used in that study to be inconclusive. Evaluation committees of the drug have been found to include members paid by GlaxoSmithKline, the maker of Avandia. Not surprisingly, those committees always made positive recommendations for Avandia.